The expression of the lncRNAs USP30-AS1, ELFN1-AS1, GAS8-AS1, and SNHG11 in breast cancer samples from Iranian patients from 2014 to 2019: a cross-sectional study

Abstract Objective Breast cancer is a widely prevalent and life-threatening malignancy that affects women worldwide. The identification of novel molecular markers associated with tumor progression is highly important for enhancing early detection, tailoring treatment approaches, and monitoring thera...

Full description

Saved in:
Bibliographic Details
Main Authors: Ghazal Orak, Zahra Orak Chahartangi, Zahra Nazeri, Fereshteh Ameli, Maryam Adelipour
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Research Notes
Subjects:
Online Access:https://doi.org/10.1186/s13104-024-07069-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544978666356736
author Ghazal Orak
Zahra Orak Chahartangi
Zahra Nazeri
Fereshteh Ameli
Maryam Adelipour
author_facet Ghazal Orak
Zahra Orak Chahartangi
Zahra Nazeri
Fereshteh Ameli
Maryam Adelipour
author_sort Ghazal Orak
collection DOAJ
description Abstract Objective Breast cancer is a widely prevalent and life-threatening malignancy that affects women worldwide. The identification of novel molecular markers associated with tumor progression is highly important for enhancing early detection, tailoring treatment approaches, and monitoring therapeutic outcomes. In this study, we investigated the expression patterns of four long noncoding RNAs (lncRNAs): USP30 antisense RNA1 (USP30-AS1), ELFN1 antisense RNA1 (ELFN1-AS1), GAS8 antisense RNA1 (GAS8-AS1), and small nucleolar RNA host gene 11 (SNHG11). Results In breast cancer specimens, USP30-AS1 and GAS8-AS1 expression was decreased, whereas ELFN1-AS1 and SNHG11 expression was increased in breast cancer tissues compared with adjacent noncancer tissues. Decreased USP30-AS1 levels were associated with a smaller tumor size, lower tumor grade and stage, and the absence of lymphatic and vascular invasion. Lower GAS8-AS1 expression was associated with a lower tumor grade and positive estrogen and progestin receptor status. Elevated ELFN1-AS1 expression was associated with breast cancer that lacked P53 mutation. These changes suggest their promise as biomarkers for distinguishing between cancerous and noncancerous tissues.
format Article
id doaj-art-716f0a1df37a460f96d61629b0d75fd6
institution Kabale University
issn 1756-0500
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Research Notes
spelling doaj-art-716f0a1df37a460f96d61629b0d75fd62025-01-12T12:06:47ZengBMCBMC Research Notes1756-05002025-01-011811810.1186/s13104-024-07069-zThe expression of the lncRNAs USP30-AS1, ELFN1-AS1, GAS8-AS1, and SNHG11 in breast cancer samples from Iranian patients from 2014 to 2019: a cross-sectional studyGhazal Orak0Zahra Orak Chahartangi1Zahra Nazeri2Fereshteh Ameli3Maryam Adelipour4Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical SciencesDepartment of Hyperlipidemia, School of Paramedicine, Ahvaz Jundishapur University of Medical SciencesDepartment of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical SciencesDepartment of Pathology, School of Medicin, Tehran University of Medical SciencesDepartment of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical SciencesAbstract Objective Breast cancer is a widely prevalent and life-threatening malignancy that affects women worldwide. The identification of novel molecular markers associated with tumor progression is highly important for enhancing early detection, tailoring treatment approaches, and monitoring therapeutic outcomes. In this study, we investigated the expression patterns of four long noncoding RNAs (lncRNAs): USP30 antisense RNA1 (USP30-AS1), ELFN1 antisense RNA1 (ELFN1-AS1), GAS8 antisense RNA1 (GAS8-AS1), and small nucleolar RNA host gene 11 (SNHG11). Results In breast cancer specimens, USP30-AS1 and GAS8-AS1 expression was decreased, whereas ELFN1-AS1 and SNHG11 expression was increased in breast cancer tissues compared with adjacent noncancer tissues. Decreased USP30-AS1 levels were associated with a smaller tumor size, lower tumor grade and stage, and the absence of lymphatic and vascular invasion. Lower GAS8-AS1 expression was associated with a lower tumor grade and positive estrogen and progestin receptor status. Elevated ELFN1-AS1 expression was associated with breast cancer that lacked P53 mutation. These changes suggest their promise as biomarkers for distinguishing between cancerous and noncancerous tissues.https://doi.org/10.1186/s13104-024-07069-zBreast cancerlncRNAUSP30-AS1ELFN1-AS1GAS8-AS1SNHG11
spellingShingle Ghazal Orak
Zahra Orak Chahartangi
Zahra Nazeri
Fereshteh Ameli
Maryam Adelipour
The expression of the lncRNAs USP30-AS1, ELFN1-AS1, GAS8-AS1, and SNHG11 in breast cancer samples from Iranian patients from 2014 to 2019: a cross-sectional study
BMC Research Notes
Breast cancer
lncRNA
USP30-AS1
ELFN1-AS1
GAS8-AS1
SNHG11
title The expression of the lncRNAs USP30-AS1, ELFN1-AS1, GAS8-AS1, and SNHG11 in breast cancer samples from Iranian patients from 2014 to 2019: a cross-sectional study
title_full The expression of the lncRNAs USP30-AS1, ELFN1-AS1, GAS8-AS1, and SNHG11 in breast cancer samples from Iranian patients from 2014 to 2019: a cross-sectional study
title_fullStr The expression of the lncRNAs USP30-AS1, ELFN1-AS1, GAS8-AS1, and SNHG11 in breast cancer samples from Iranian patients from 2014 to 2019: a cross-sectional study
title_full_unstemmed The expression of the lncRNAs USP30-AS1, ELFN1-AS1, GAS8-AS1, and SNHG11 in breast cancer samples from Iranian patients from 2014 to 2019: a cross-sectional study
title_short The expression of the lncRNAs USP30-AS1, ELFN1-AS1, GAS8-AS1, and SNHG11 in breast cancer samples from Iranian patients from 2014 to 2019: a cross-sectional study
title_sort expression of the lncrnas usp30 as1 elfn1 as1 gas8 as1 and snhg11 in breast cancer samples from iranian patients from 2014 to 2019 a cross sectional study
topic Breast cancer
lncRNA
USP30-AS1
ELFN1-AS1
GAS8-AS1
SNHG11
url https://doi.org/10.1186/s13104-024-07069-z
work_keys_str_mv AT ghazalorak theexpressionofthelncrnasusp30as1elfn1as1gas8as1andsnhg11inbreastcancersamplesfromiranianpatientsfrom2014to2019acrosssectionalstudy
AT zahraorakchahartangi theexpressionofthelncrnasusp30as1elfn1as1gas8as1andsnhg11inbreastcancersamplesfromiranianpatientsfrom2014to2019acrosssectionalstudy
AT zahranazeri theexpressionofthelncrnasusp30as1elfn1as1gas8as1andsnhg11inbreastcancersamplesfromiranianpatientsfrom2014to2019acrosssectionalstudy
AT fereshtehameli theexpressionofthelncrnasusp30as1elfn1as1gas8as1andsnhg11inbreastcancersamplesfromiranianpatientsfrom2014to2019acrosssectionalstudy
AT maryamadelipour theexpressionofthelncrnasusp30as1elfn1as1gas8as1andsnhg11inbreastcancersamplesfromiranianpatientsfrom2014to2019acrosssectionalstudy
AT ghazalorak expressionofthelncrnasusp30as1elfn1as1gas8as1andsnhg11inbreastcancersamplesfromiranianpatientsfrom2014to2019acrosssectionalstudy
AT zahraorakchahartangi expressionofthelncrnasusp30as1elfn1as1gas8as1andsnhg11inbreastcancersamplesfromiranianpatientsfrom2014to2019acrosssectionalstudy
AT zahranazeri expressionofthelncrnasusp30as1elfn1as1gas8as1andsnhg11inbreastcancersamplesfromiranianpatientsfrom2014to2019acrosssectionalstudy
AT fereshtehameli expressionofthelncrnasusp30as1elfn1as1gas8as1andsnhg11inbreastcancersamplesfromiranianpatientsfrom2014to2019acrosssectionalstudy
AT maryamadelipour expressionofthelncrnasusp30as1elfn1as1gas8as1andsnhg11inbreastcancersamplesfromiranianpatientsfrom2014to2019acrosssectionalstudy